358672-62-5Relevant academic research and scientific papers
Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
-
, (2008/06/13)
A combination therapy of at least one FBPase inhibitor and at least one other antidiabetic agent is disclosed.
Novel aryl fructose-1,6-Bisphosphatase inhibitors
-
, (2011/12/16)
Novel FBPase inhibitors of the formula I 1are useful in the treatment of diabetes and other conditions associated with elevated blood glucose.
